Abietic and dehydroabietic acid are interesting diterpenes with a highly diverse repertoire of associated bioactivities. They have, among others, shown antibacterial and antifungal activity, potentially valuable in the struggle against the increasing antimicrobial resistance and imminent antibiotic shortage. In this paper, we describe the synthesis of a set of 9 abietic and dehydroabietic acid derivatives containing amino acid side chains and their in vitro antimicrobial profiling against a panel of human pathogenic microbial strains. Furthermore, their in vitro cytotoxicity against mammalian cells was evaluated. The experimental results showed that the most promising compound was 10 [methyl N- (abiet-8,11,13-trien-18-yl 
Introduction
The occurrence of antibiotic-resistant microorganisms is not a new phenomenon, but it has been getting more accentuated during recent years, partly due to the emergence of multidrug-resistant strains, together with a stagnating development of novel antibiotics. The spread of multidrugresistant bacteria and fungi poses a serious threat to the successful management of infections and has as such a growing impact on both quality and cost of the health care system. 1 To face this challenge, not only improved antimicrobial stewardship, but also new antimicrobial drugs are needed. Natural products from plants, fungi and bacteria have a strong track record for having antimicrobial activity. Case in point, the screening of natural products for antibiotic activity has a higher success rate than an approach based on pure combinatorial chemistry. 2 A pair of natural products that deserves our particular interest is found in many conifers around the globe: Abietic acid (1) and dehydroabietic acid (1a) (Scheme 1) are diterpenoids that boast an intriguing and wellstudied bioactivity profile, including antiviral, antibiotic and antifungal activity. 
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Search for related compounds in online databases
In order to survey supplementary information about bioactivity of similar compounds, as well as to postulate a possible mode of action, we searched the ChEMBL and PubChem databases for chemically similar structures (similarity threshold of 90). This was done using ChEMBL web services, but due to the technical limitations of the interface, some stereochemical properties of the molecules could not be submitted. We examined the returned literature lists to gather information about bioactivities reported for similar compounds and, if applicable, for their mode of action.
We also compared molecular fingerprints of the active compounds with known antibiotics. The structures were retrieved from ChEMBL by searching for ATC code "J". We then calculated the Tanimoto similarity between the optimized compound set and the known anti-infectives using RDKit.
Results and discussion
Abietic acid (1) has been widely studied for its bioactivity, and our findings reinforce its position as a promising parent structure for the synthesis of novel, bioactive compounds. They contribute to the body of knowledge related to compound 1 and deepen the understanding of the potential and properties of 1 and its derivatives.
Antimicrobial screening
As a response to the upcoming shortage of potent antibiotics, this study first and foremost aimed to evaluate the antimicrobial potential of amino acid derivatives of abietic acid (1) . Although the antiproliferative activity of amino acid-based derivatives of 1 has been previously reported, 17, 22 there is yet no detailed study to address their potential antimicrobial properties. Moreover, our previous work showed that the combination of amino acids with an abietane core, such as that of 1a, resulted Table 2 . It shows noteworthy activity of 10 against S. epidermidis and S. mitis (MIC 90 8 µg/mL). Previous work has described derivatives of 1 and 1a with comparable potency (MIC against S. aureus between 5 and 20 µM corresponding to 2-8 µg/mL, 23, 25 ) , and it has been suggested that compounds isolated from natural products could be considered interesting if their MIC lies below 10 µg/mL. 
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Cytotoxicity against mammalian cells
The quality of an antibiotic candidate is not only determined by its capability to affect bacteria, but the compound must also be innocuous to human cells. Therefore, we conducted cytotoxicity experiments against mammalian cells to estimate the selectivity of the compound effects between microbial and mammalian cells. The reported cytotoxicity of abietic acid 1 derivatives varies, and cytotoxic compounds with IC 50 values below 10 µM as well as relatively innocuous compounds with IC 50 values above 100 µM against both skin fibroblasts and human metastatic melanoma cells have been described. 14 Within this context, the cytotoxicity of our derivatives seems to be at moderate level. Still, cytotoxicity against mammalian cells can be a serious unwanted effect of derivatives of 1, which highlights the need for evaluating it as early as possible.
Bioactivity of related compounds
Knowing that a broad spectrum of bioactivities has been described for abietic acid 1 and related compounds, we looked for entries of the compounds in this study in the online databases ChEMBL, ChEMBL496686 (see Supplementary material, Fig. A.2. ), described as a neuroprotective agent that inhibits the activation of p38 MAPK and JNK in murine HT22 cells. 31 In addition, based on our selection criteria, we downloaded the structures of 323 antibiotics from ChEMBL. However, none of them showed a similar fingerprint to abietic acid 1 or its derivatives (max value: 0.22). While a high similarity would have been useful for the elucidation of the mode of action, the absence is also encouraging; 1 and/or its derivatives may act in a novel way to be explored in future studies. 
Conclusions
In this study, we have identified the serine derivatives ( induce resistance is low due to apparently fast-killing membrane targeting effects. Future efforts should focus on optimization of their potency and selectivity, and on studying their activity against a broader microbial spectrum as well as other pathologic targets.
